|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.06 USD | +0.37% |
|
-0.17% | +6.37% |
| Jan. 20 | RBC Raises Price Target on Incyte to $95 From $92, Keeps Sector Perform Rating | MT |
| Jan. 20 | Wells Fargo Downgrades Incyte to Equalweight From Overweight, Adjusts PT to $107 From $116 | MT |
Evolution of the Average Target: Incyte Corporation
Evolution of the Target Price: Incyte Corporation
Changes in Analyst Recommendations: Incyte Corporation
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | -2.6% | |||||
| +9.86% | |||||
| +26.55% | |||||
| +28.94% | |||||
| +2.05% | |||||
| +9.86% | |||||
| -27.9% | |||||
| +37.51% | |||||
| +12.36% | |||||
| - | - | - | |||
| Average | +10.74% | |||||
| Weighted average by Cap. | +13.07% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| RBC Capital Markets | |
| Wells Fargo Securities | |
| Guggenheim | |
| TD Cowen | |
| Goldman Sachs | |
| Morgan Stanley | |
| Truist Securities | |
| Leerink Partners | |
| Mizuho Securities | |
| Barclays | |
| Jefferies & Co. | |
| Piper Sandler | |
| Argus | |
| Oppenheimer | |
| Stifel Nicolaus | |
| Deutsche Bank Securities | |
| BMO Capital | |
| JPMorgan Chase | |
| Wolfe Research | |
| UBS | |
| Citigroup | |
| BofA Securities | |
| William Blair & Co. | |
| JMP Securities | |
| SVB Securities LLC | |
| Morningstar | |
| Cowen | |
| Evercore ISI | |
| SVB Leerink | |
| Benchmark Capital | |
| Credit Suisse |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INCY Stock
- Consensus Incyte Corporation
Select your edition
All financial news and data tailored to specific country editions
